A heart transplant is a surgery that replaces a failing heart with a healthy heart from a deceased donor. It’s reserved for people with end-stage heart failure whose condition can no longer be managed with medications, lifestyle changes, or less invasive procedures. About 92% of adult recipients survive the first year, and roughly 80% are alive five years later.
Why Someone Might Need a New Heart
Heart transplants aren’t a first option. They’re considered when every other treatment has been exhausted and the heart is too damaged to pump blood effectively. The most common reason is end-stage heart failure, where the heart muscle has weakened so severely that it can no longer support the body’s basic needs. This can result from coronary artery disease, long-standing high blood pressure, viral infections that damage the heart muscle, or inherited conditions that cause the heart to enlarge or stiffen over time.
Some people reach this point gradually over years. Others arrive suddenly after a massive heart attack destroys a large portion of heart tissue. In either case, the defining feature is the same: the heart cannot recover, and without a transplant, life expectancy is very limited.
Who Qualifies for the Transplant List
Getting listed for a heart transplant involves extensive screening to ensure the surgery is likely to succeed and that no other condition would limit the benefit of a new heart. Candidates must be healthy enough in every other organ system to survive the surgery and tolerate a lifetime of immune-suppressing medications afterward.
Several conditions can disqualify someone. Severe, irreversible kidney or liver disease makes the body too fragile to handle the procedure and recovery. A history of cancer within the past five years raises concern that immune-suppressing drugs could allow the cancer to return. Significant peripheral or cerebrovascular disease, active infections, uncontrolled diabetes with organ damage, and elevated pressure in the blood vessels of the lungs are all potential barriers. Tobacco and substance use are also disqualifying factors, as is severe obesity.
Beyond physical health, transplant programs evaluate whether a candidate has the psychological stability and social support system to manage the demanding post-transplant regimen. Taking medications on schedule, attending frequent follow-up appointments, and making permanent lifestyle changes are non-negotiable parts of life with a transplanted heart.
How Donor Hearts Are Matched and Allocated
The national organ allocation system ranks adult heart transplant candidates across six levels of medical urgency, from Status 1 (most urgent) to Status 6 (least urgent). Patients in Status 1 or 2 are considered first for available hearts from a wider geographic area, reflecting their critical need. Children under 18 are ranked on a separate scale with different medical criteria.
Matching goes beyond urgency. Blood type compatibility, body size, and the distance between the donor hospital and the recipient’s transplant center all factor in. That distance matters enormously because a donor heart can only survive about four hours outside the body using traditional cold storage before the risk of damage rises sharply. Experimental preservation techniques are extending that window, but the clock remains one of the biggest constraints in heart transplantation.
What Happens During the Surgery
The operation begins with an incision down the center of the chest through the breastbone. The patient is then connected to a heart-lung bypass machine, which takes over the work of circulating blood and delivering oxygen while the surgical team removes the failing heart.
The most widely used approach is called the bicaval technique, which preserves the normal shape of the heart’s upper chambers and protects the natural pacemaker tissue. The surgeon connects the donor heart to the major blood vessels: the aorta, the pulmonary artery, and the veins returning blood from the body and lungs. Each connection is stitched carefully and inspected for leaks. Temporary pacing wires are placed on the new heart in case it needs electrical support in the early days of recovery. Before the chest is closed, the surgical team uses ultrasound imaging to confirm that all air has been cleared from the heart chambers.
The entire procedure typically takes several hours, though the exact duration varies depending on whether the patient has had prior chest surgeries or other complicating factors.
Recovery in the Hospital and Beyond
After surgery, you’ll spend roughly one week in the intensive care unit, where the medical team closely monitors how the new heart is functioning and watches for early signs of complications. Most people are up and walking within a few days. The total hospital stay runs 10 to 14 days if recovery goes smoothly.
The first three to six months after transplant are the highest-risk period for rejection and require the most intensive monitoring. During this window, you’ll have frequent clinic visits, blood tests, and heart biopsies. Most people feel healthy enough to return to normal daily activities within about six months.
How the Body Can Reject a New Heart
Your immune system is designed to attack foreign tissue, and a transplanted heart is no exception. Rejection is a constant concern, managed but never fully eliminated by medications. There are two main types.
Acute cellular rejection is the more common form, especially in the first three to six months. In a study tracking rejection after discharge through the first year, about 12% of patients experienced moderate to severe episodes. The immune system’s white blood cells infiltrate the heart muscle and damage it directly. Symptoms can include fatigue, shortness of breath, fever, or fluid retention, though some episodes produce no noticeable symptoms at all.
Antibody-mediated rejection is less common but can be more difficult to treat. Instead of cells attacking the heart directly, the immune system produces antibodies that target the blood vessels within the donor heart.
To catch rejection early, transplant centers perform endomyocardial biopsies, a procedure where a thin catheter is threaded through a vein to collect a tiny sample of heart tissue for examination under a microscope. Newer approaches, including blood tests that detect DNA fragments shed by the donor heart, are increasingly used alongside biopsies to monitor for trouble.
Lifelong Medications and Their Trade-Offs
Every heart transplant recipient takes immune-suppressing medications for the rest of their life. These drugs prevent rejection but come with significant side effects because they weaken the body’s natural defenses. The regimen typically combines drugs from several classes, each working through a different mechanism to keep the immune system in check.
Steroids are almost universally used and carry the longest list of side effects. They can cause high blood pressure, weight gain (particularly around the face and torso), thinning skin, easy bruising, cataracts, bone loss, elevated cholesterol, and diabetes. Emotional mood swings are common. In children, they can slow growth.
Calcineurin inhibitors are the backbone of most transplant drug regimens. Their most serious long-term effect is kidney damage, which can become chronic over years. They also contribute to high blood pressure, elevated cholesterol, tremor, headaches, and new-onset diabetes in roughly 10% of patients within the first year. One version causes excess hair growth and swollen gums, while another can cause hair thinning.
Other drugs in the regimen may cause digestive problems like nausea and diarrhea, suppress bone marrow function (leading to low blood cell counts), or elevate blood fats. One class of drugs can impair wound healing and cause a specific type of lung inflammation. Because these medications dampen the immune system broadly, transplant recipients face a higher lifelong risk of infections and certain cancers.
The goal is always to find the lowest effective dose of each drug, balancing rejection prevention against these side effects. Adjustments are common, especially in the first year.
Diet and Lifestyle After Transplant
Living with a transplanted heart means permanent changes to how you eat. Because immune-suppressing drugs raise cholesterol, blood pressure, blood sugar, and the tendency to retain fluid, your diet needs to actively counteract those effects.
Sodium restriction is one of the most important adjustments. A no-added-salt approach is standard: you can use small amounts of salt during cooking, but nothing extra at the table. Highly processed foods like cured meats, canned soups, frozen meals, and regular cheeses should be limited. Sugar and concentrated sweets need to be kept moderate to help control blood sugar, which the medications tend to push upward. Fat intake shifts toward leaner proteins (fish, poultry, lean red meat), non-fat dairy, and unsaturated fats, while egg yolks and high-fat dairy are reduced.
Maintaining a healthy weight is critical. Extra weight strains the new heart and worsens the metabolic side effects of transplant medications. Most transplant centers work with dietitians to help recipients develop an eating plan they can sustain long-term.
Survival and Quality of Life
Outcomes have improved steadily over the decades. For transplants performed in 2018, the mortality rate was about 8% at one year, meaning roughly 92 out of 100 recipients survived their first year. At five years, about 80% of recipients were still alive. Mortality at three years was approximately 14%.
These numbers represent averages across all adult recipients. Individual outcomes vary based on age, overall health before transplant, how well the donor heart matches, and whether complications like rejection or infection occur early on. Many recipients return to work, exercise, travel, and live active lives for years or even decades after their transplant.